跳至主要内容
临床试验/CTRI/2023/03/050364
CTRI/2023/03/050364尚未招募4 期

Prospective, randomized, comparative clinical investigation to evaluate and compare the performance & safety of two different OVDs in patient undergoing cataract surgery.

Biotech Ophthalmics Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Inclusion Criteria:
  • 1) Unilateral/Bilateral
  • 2) Age18yearorgreater
  • 3) Cataractforwhichphacoemulsificationextractionandposterior
  • chamber IOL implantation was planned in at least one eye of the
  • 4) Clearintraocularmediaotherthancataract
  • 5) Signedinformedconsent
  • 6) Patient who are willing to attend all the regular follow-up
  • examinations as per the study schedule.

排除标准

  • 1) Concurrent participation or participation in the last 30 days in any other clinical trial.
  • 2) Historyofprevioussteroid-inducedIOP
  • 3) Patient with pigment dispersion syndrome
  • 4)Taking medications that may affect vision,IOP,or ease of cataract
  • surgery (e.g., Flomax, glaucoma medications, etc.)
  • 5) Acute or chronic disease or illness that would increase risk or
  • confound study results (e.g., diabetes mellitus,
  • immunocompromised, etc.)
  • 6) Uncontrolledsystemicoroculardisease.
  • 7) Historyofoculartraumaorpriorocularsurgery
  • 8) Corneal abnormalities (e.g., stromal, epithelial or endothelial
  • dystrophies)
  • 9) Knownpathologythatmayaffectvisualacuity;particularlyretinal
  • changes that affect vision (e.g., macular degeneration, cystoid
  • macular edema, diabetic retinopathy, etc.)
  • 10) Any visual disorder predicted to cause future acuity loss to a level
  • of 0.3 LogMAR or worse
  • 11) Pseudoexfoliation
  • 12) Ocular hypertension ( >22 mm Hg) or glaucomatous changes in the
  • optic nerve.
  • 13) Endothelial cell counts lower than 1500 cells/mm2 preoperatively
  • (based on the lowest value of three cell counts performed by
  • technician at investigative site)
  • 14) Patient is pregnant, planned to become pregnant, lactating or had
  • another condition associated with the fluctuation of hormones that
  • could lead to refractive changes
  • 15) Vulnerable subject.

研究者

发起方
Biotech Ophthalmics Pvt Ltd

相似试验